Molecular characterization of an HIV-1 drug target and antiviral compound development
The Human Immunodeficiency Virus -1 (HIV-1) has been the source of substantial human misery since it was first discovered in the early 1980s. Despite remarkable progress that has been made towards understanding HIV- 1, there is no cure, no vaccine and life-prolonging therapies are beyond the reach o...
Main Author: | Maselko, Maciej |
---|---|
Other Authors: | Pastey, Manoj |
Language: | en_US |
Published: |
2011
|
Subjects: | |
Online Access: | http://hdl.handle.net/1957/21160 |
Similar Items
-
Antiviral mechanism of polyanionic carbosilane dendrimers against HIV-1
by: Vacas-Córdoba E, et al.
Published: (2016-04-01) -
Inhibition of HIV-1 infection by aqueous extracts of <it>Prunella vulgaris </it>L.
by: McCoy Joe-Ann, et al.
Published: (2011-04-01) -
Efficacy of HIV antiviral polyanionic carbosilane dendrimer G2-S16 in the presence of semen
by: Ceña-Diez R, et al.
Published: (2016-05-01) -
Application and removal of polyanionic microbicide compounds enhances subsequent infection by HIV-1
by: Pirrone Vanessa, et al.
Published: (2012-01-01) -
Immune defense of the female lower reproductive tract and the use of monoclonal antibody-based topical microbicide films to protect against HIV infection
by: Costanzo, Corey
Published: (2016)